Proton decoupled fluorine nuclear magnetic resonance spectroscopy in situ  by Berkowitz, B.A. & Ackerman, J.J.
BRIEF COMMUNICATION
PROTON DECOUPLED FLUORINE NUCLEAR MAGNETIC
RESONANCE SPECTROSCOPY IN SITU
BRUCE A. BERKOWITZ AND JOSEPH J. H. ACKERMAN
Department of Chemistry, Washington University, St. Louis, Missouri 63130
ABSTRACT The efficacy of proton decoupling for enhancing the '9F nuclear magnetic resonance (NMR) signal-
to-noise ratio and spectral resolution in the intact subject is demonstrated. A geometrically orthogonal cross-coil
antenna configuration (Helmholtz pair, surface coil) is employed to provide 40 dB of isolation between the '9F observe
and 'H decouple frequencies of 188 and 200 MHz, respectively. Further isolation is achieved through the use of
high-quality notch filters on both observation and decoupling channels. Application of '9F-{I'H} NMR spectroscopy to
the study of 2-fluoro-2-deoxy-D-glucose metabolism in cerebral tissue in situ is presented. Significant improvements in
sensitivity and resolution are obtained and result from both a collapse of the JFH multiplet structure and a substantial
positive nuclear Overhauser effect (NOE). To our knowledge, this is the first such demonstration of 'H decoupling in
conjunction with '9F observation for study of the metabolism of a fluorinated compound in the living subject.
INTRODUCTION
Nuclear magnetic resonance (NMR) spectroscopy, cou-
pled with surface coil technology (1), has become an
important noninvasive approach to studying evolving
metabolism in situ. Naturally occurring, nonradiative, spin
'/2 labels such as 'H, '3C, and 31P have proven useful in
elucidating metabolism in vivo. The '9F nuclide offers
many advantages as an exogenous spin l/2 label including a
large spectral dispersion (-500 ppm), high sensitivity
(-0.8 that of 'H), and a natural abundance of 100%. The
negligible endogenous fluorine concentration eliminates
spectral background interference in tissue and, thus, in
principle, '9F NMR analysis of the metabolism of a
fluorine-labeled substrate in situ can be readily accom-
plished (2, 3).
A potential problem encountered when using a fluorine
label for studying metabolism is scalar coupling interac-
tions with neighboring protons. In the case of '9F-'H scalar
couplings (JFH) on the order of or greater than the suscepti-
bility inhomogeneity broadened tissue resonance line-
widths (AV,/2 tissue -0.2-0.4 ppm), one can expect a
marked decrease in the apparent frequency resolution (i.e.,
an increase in the observed linewidth) compared with the
frequency resolution in the absence of the JFH interaction.
Under these circumstances (and in the absence of a
negative nuclear Overhauser effect (NOE), vide infra), the
narrower lines of the proton decoupled '9FNMR spectrum
should present a higher apparent signal-to-noise ratio than
the proton coupled spectrum.
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Proton decoupling is routinely used in '3C NMR to
collapse multiplet patterns produced by '3C-'H scalar
coupling interactions and thereby simplify the spectrum;
additional signal enhancement is achieved via the NOE.
Because of the substantial difference between the radio
frequencies (rf) of the observe and decouple channels in the
13C-{_'H experiment, appropriate double resonance circuit
design is straightforward and many isolation schemes have
been reported and utilized to good effect. Unfortunately,
unlike the '3C-{'H} experiment the '9F and 'H nuclides are
separated by only -6% in frequency, making proton decou-
pling while observing fluorine a potentially difficult prob-
lem with regard to achieving adequate rf isolation between
the observe and decouple channels while maintaining
receiver efficiency.
In the case of low molecular weight, highly mobile
fluorinated compounds, a theoretical increase in '9F sensi-
tivity of 53% through the 9F-'H NOE can be achieved
upon 'H decoupling (4) in addition to the signal-to-noise
increase resulting from collapse of the JFH multiplet struc-
ture. However, Hull and Sykes (5) have reported that less
mobile fluorinated molecules can experience decreases in
sensitivity through the (negative) NOE. Therefore, fluori-
nated compounds existing outside the extreme narrowing
regime, and which might be found in vivo, may require the
use of special gated decoupling techniques to avoid sensi-
tivity losses due to adverse (i.e., negative) NOE effects.
Herein we demonstrate the resolution and signal-to-
noise enhancements that can be obtained through the use
of a geometrically orthogonal cross-coil antenna configura-
tion for proton decoupling of fluorine metabolites in the
intact functioning subject in situ. This orthogonal configu-
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ration provides excellent frequency-independent rf isola-
tion, optimizes the '9F observation and 'H decoupling
antenna efficiency, and is easily implemented in a standard
vertical wide-bore, high-field, high-resolution NMR spec-
trometer.
EXOGENOUS FLUORINATED METABOLIC
SUBSTRATE
Powerful radiological imaging techniques employing '8F
labeled 2-fluoro-2-deoxy-D-glucose (2FDG) have been
applied to map local cerebral glucose utilization rates in
humans (6, 7). Due to near exclusive use of glucose as a
cerebral energy source, this map of cerebral glucose utili-
zation rates can, in principle, be interpreted as a map of
regional cerebral activity (6, 7). However, recent contro-
versy over the metabolic fate of deoxy-glucose analogues
and, thus, their applicability as quantitative monitors of
cerebral activity (8) has motivated the development of '9F
NMR techniques to delineate 2FDG metabolism in situ
(9-12).
The sensitivity of the fluorine nuclide to the scalar
coupling of neighboring protons is illustrated in the high
resolution, proton coupled and decoupled 19F NMR spec-
tra of a mixture of 2FDG and its hexokinase phosphoryla-
tion product 2-fluoro-2-deoxy-D-glucose-6-phosphate
(2FDG6P) in aqueous solution (Fig. 1). The proton decou-
pled '9F spectrum of 2FDG and 2FDG6P contains four
primary resonances reflecting glucose anomerization,
namely the 3 and a forms (Fig. 1 A). Progressively
increasing the mole fraction of 2FDG6P by stepping of the
ATP concentration in a reaction mixture of 2FDG, KCl
and/or MgCl2, and hexokinase provided positive differen-
tiation of those resonances due to 2FDG and 2FDG6P in
the high resolution proton decoupled 19F NMR spectrum.
Relative to trifluoroacetate, which was used as an internal
19F chemical shift reference and assigned to 0.00 ppm, the
a, ,B anomers of 2FDG and 2FDG6P have shifts of
-123.84, -123.68, -123.92, and - 123.66 ppm, respec-
tively (370C, 120 mM ionic strength, pH = 7.1). These
assignments are similar but somewhat in contrast to those
reported elsewhere (9, 14). These shifts were found to be
insensitive to ionic strength variations about the physio-
logic norm, 120-180 mM. Furthermore, in comparing
shifts from a solution containing a high concentration of
monocation (90 mM KCl, 2 mM MgCl2) with a solution
containing a high dication concentration (0 mM KCl, 48
mM MgCl2), no marked '9F chemical shift perturbations
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FIGURE 1 Fluorine NMR spectra of 2FDG (Behring Diagnostics, American Hoechst Corp., San Diego, CA) and its phosphorylated
product 2FDG6P obtained under proton decoupled (A) and proton-coupled (B) conditions. For definitive identification of the anomer
resonances of 2FDG and 2FDG6P, the composition of a solution of 2FDG and 2FDG6P was varied from 100% 2FDG to 100% 2FDG6P by a
modification of the procedure of Bessell and Thomas (14). The solution composition (relative amounts of substrate 2FDG and product
2FDG6P) was varied in a stepwise manner by phoshorylation with yeast hexokinase (Sigma Chemical Co., St. Louis, MO) with the extent of
reaction limited by added ATP. Ionic strength was maintained about the physiologic norm (- 120-180 mM) with pH = 7.1 and temperature =
37°C; 20% D20 was used as an internal lock and trifluoroacetate (1.4 mg/ml) was present as an internal '9F chemical shift reference. The
reaction was followed by monitoring the pH. The final pH was adjusted to 7.1 and an aliquot was taken for '9F NMR analysis. Time domain
data was acquired on a pulsed Fourier transform NMR spectrometer (model FX-100; JEOL USA, Analytical Instruments Div, Peabody,
MA) operating at 93.67 MHz for '9F detection. Spectra represent 4 h of data acquisition (2 K data points, 1 kHz band width, 1.5 s pulse
repetition period). Fourier transformation was performed after zero filling to 16 K; no sensitivity enhancing digital filtering was employed.
IUPAC chemical shift convention was followed (22) with the jB-anomer of 2FDG6P (decoupled) arbitrarily assigned 0.0 ppm in this figure;
actual assignment is -123.66 ppm relative to trifluoroacetate as an internal standard. Spectral assignments and multiplet patterns are more
fully discussed in text. In (A) the small peak to lower frequency is unassigned. Abscissa divisions are in units of 0.2 ppm.
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ascribable to cation interactions (with the electronegative
fluorine or phosphate group) were detected.
The presence of JFH interactions splits each anomer
resonance into distinct multiplet patterns (Fig. 1 B), which
have been analyzed previously (9, 13); the multiplet pat-
tern due to JFH of 2FDG6P is very similar to that described
for 2FDG (9, 14). The largest coupling of -50 Hz is due to
the geminal proton on the C-2 carbon. The vicinal proton
on the C-3 carbon of 2FDG and 2FDG6P provides a 15-Hz
coupling that further splits each resonance. Finally, when
the vicinal proton on the C- carbon is axial (i.e., when the
glucose analogue is in the f3-anomer form) a 2.5-Hz
coupling is observed under high resolution conditions; if
this vicinal proton is equatorial (a-anomer), then it does
not couple with the fluorine on the C-2 carbon to any
significant extent. Based on the presence and absence of
the JFH interaction with the vicinal proton at C-1, the two
proton decoupled resonances at high frequency in Fig. 1 A,
are identified as the f3-anomers. The 50 Hz geminal JFH
interaction is clearly on the order of the tissue resonance
linewidth in situ and so proton decoupling can be expected
to significantly enhance the observed frequency resolution
in the '9FNMR spectrum of2FDG and 2FDG6P in tissue.
In the absence of a negative NOE, a signal-to-noise
enhancement should result from this increased resolution.
'9F-{'HI NMR METHODOLOGY IN SITU
The orthogonal cross-coil antenna configuration employed
herein made use of a two-turn (2-cm outer diam.) space-
wound surface coil tuned for '9F at 188.154 MHz. The
proton decoupling circuit is independent of this observation
antenna; it is constructed from two 3-cm outer diam. single
turn loops connected in parallel in a Helmholtz configura-
tion tuned for 'H at 200 MHz. Standard capacitive tuning
to the resonance frequency and for a 50 Q impedance
match was employed for both circuits. Fig. 2 illustrates the
relative position of the observation and decoupling coils on
the head of a rat. Radio-frequency isolation is achieved by
optimizing geometrical orthogonality between the observe
surface coil and the Helmholtz decoupling coil with an
animal in place. Typical isolation between the observe and
decouple channels is 40 dB (measured at 2 W decoupling
power). Additional isolation is achieved by the use of a
series of high efficiency rf cavity resonator notch filters
outside the bore of the magnet on both the '9F observation
and 'H decouple channels (-35 dB rejection, -0.4 dB
insertion loss; Celwave, Inc., Marlboro, NJ). No increase
in the noise level of the '9F spectrum during 'H decoupling
was observed with this configuration.
RESULTS AND DISCUSSION
The utility of proton decoupling '9F resonances in situ was
investigated after intravenous administration of the glu-
cose analogue 2FDG (200 mg/kg). The LD50 for this
compound is -600 mg/kg/day i.p. for five consecutive
days (15). A nonfluorine containing mixture of ketamine/
1 H decouple
19 F observe
FIGURE 2 Artist's rendering, at an oblique angle, of the relative position
of the '9F observation surface coil and Helmholtz 'H decoupling coil on a
rat head. At this angle, the two-turn stacked surface coil appears as a
single loop. Coupling between the two antennas, measured as 'H radio
frequency feedthrough on the observation channel, is minimized by
optimizing geometrical orthogonality. Further reduction in coupling is
achieved by physical isolation of the observation coil tuning network from
the decoupling coil tuning network. This provides 40 dB of isolation
between the two channels (in the absence of additional filtering, see text)
with the animal in place.
xylaxine (87 mg/kg: 13 mg/kg) was administered intra-
muscularly to maintain the subject, an -250-g male
Sprague-Dawley rat, under anesthesia throughout the
experiment (16).
All NMR experiments in vivo were performed on a
4.7-T pulsed Fourier transform NMR spectrometer
(model CXP-200; Bruker Instruments, Inc., Billerica,
MA) with a room temperature shim bore of 8.5-cm inner
diam. Static magnetic field homogeneity was optimized in
situ by shimming on the proton NMR signal of water in
cerebral tissue through the observation antenna (17).
Spectra were collected at 5-min intervals under broad-
band gated decoupling conditions in 8 K data blocks with a
spectral width of 20 kHz, an observation pulse repetition
period of 0.454 s, and a pulse width of 7 ,us at 100 W. The
proton decoupler was gated on at 3.2 W during the
acquisition time (0.255 s) and then gated off for the rest of
the pulse repetition period to achieve an average power of
1.8 W in order to minimize rf tissue heating effects. This
decoupler gating scheme may also be expected to reduce
the NOE effect. A sealed microsphere (Wilmad Glass Co.,
Inc., Buena, NJ) containing 0.5% hexafluorobenzene and
70 mM chromium acetylacetonate (as a relaxation agent)
in benzene was used as an external reference.
Fig. 3 illustrates three consecutive '9F NMR spectra of
brain tissue in situ under either proton coupled (Fig. 3 B)
or decoupled (Fig. 3, A and C) conditions taken -2 h post
injection of 2FDG. In Fig. 3 B only two fluorine resonances
(a and b) are readily observable under proton coupled
conditions where lineshapes are broadened by unresolved
JFH. In contrast, three additional resonances (c-e) are
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FIGURE 3 In situ cerebral '9F spectra taken -2 h after a 50-mg bolus
i.v. injection of 2FDG into an -250-g mole Sprague-Dawley rat anesthe-
tized with a nonfluorine containing anesthetic (see text). Spectra A-C
represent three consecutive 10-min time domain data accumulations
under proton decoupled (A and C) and proton coupled (B) conditions.
Decoupled spectra A and C were taken just before (A) and after (C) to
acquisition of coupled spectrum B. At this point in the metabolic time
course of 2FDG the proton-coupled spectrum shows only two resonances
(a and b). Proton-decoupling improves spectral resolution and sensitivity
revealing three additional resonances (c-e). Resonance a in A has been
assigned to primarily 2FDG6P (see text). Nakada and Kwee (23) have
identified resonance b as 2-fluoro-2-deoxy-glycerol, resonance c as 2-
fluoro-2-deoxy-D-sorbitol, and resonance d as 2-fluoro-2-deoxy-L-glycer-
aldehyde; resonance e remains unassigned. In some subjects, an addi-
tional resonance (f) at + 2 ppm, identified as 2-fluoro-2-deoxy-6-
phosphogluconate (9, 10), is also observed. Resonance b in the resolution
enhanced insert is labeled as two peaks (b, and b2), however, due to a low
signal-to-noise ratio this assessment is tentative. IUPAC chemical shift
convention (22) has been followed with the chemical shift of resonance
(a,) (A, insert), which arises primarily from the f,-anomer of 2FDG6P
(see text), arbitrarily assigned 0.0 ppm in this figure.
detected under proton decoupled conditions (Fig. 3, A and
C) illustrating the marked sensitivity improvement that
can be obtained by collapsing the complex JFH multiplet
patterns (e.g., Fig. 1). For the set of spectra shown in Fig.
3, the linewidth at half height (Av,/2) for the intense
resonance a attributable to the overlapping resonance lines
of 2FDG and 2FDG6P (vide infra) decreases from 15
Hz in the absence of 'H decoupling to 80 Hz in the
presence of 'H decoupling. The signal-to-noise ratio for
this resonance increased approximately 45% with proton
decoupling. This increased sensitivity and linewidth resolu-
tion allows post facto resolution enhancement techniques
to be used to good advantage for structure-shift assign-
ments. For example, as is seen in Fig. 3 A, insert, Lorent-
zian-to-Gaussian lineshape transformation (18) resolves
the intense fluorine resonance (a) (2FDG and 2FDG6P)
into two peaks (a,, a2) with a chemical shift difference of
0.23 ppm. Peak a, represents the overlapping f3-anomer
resonances of both 2FDG and 2FDG6P while peak a2
represents their overlapping a-anomer resonances. Quali-
tative peak analysis based on this chemical shift difference'
indicates that the concentration ratio of 2FDG6P/2FDG is
-2.5:1 at this point in the time course of 2FDG metabo-
lism. This supports the given assignment of these reso-
nances primarily to the a- and /3-anomers of 2FDG6P.
The extent of the '9F-{'H} NOE in vivo was measured by
comparing signal intensities (peak heights and areas gave
similar results with the most intense resonance, 2FDG6P)
from spectra obtained with the decoupler gated off (no
NOE) or left on (with NOE) during the "relaxation
period" between sequential free induction decay acquisi-
tions. A pulse repetition period of 7 s, about seven times the
longest T, in vivo (2FDG6P), provided for near quantita-
tive analysis (-5% error) of the NOE (19). The decoupler
was left on during data acquisition to remove JFH struc-
ture.
Time domain data were collected in 1 0-min time averag-
ing blocks alternating between blocks with or without
NOE over a 1-2 h period. Data collection was initiated 1.5
h postinjection of 2FDG (200 mg/kg, i.v.) into ketamine/
xylazine anesthetized rats (n = 2). Except for the extended
pulse repetition period, the acquisition parameters
and decoupler power level were the same as employed
previously.
For each of the two animals examined, all data blocks
with NOE were summed (to improve signal-to-noise) and
19F signal intensities were compared with those from the
summed data blocks taken without NOE. Each of the four
resonances quantified exhibited a substantial positive
NOE. The '9F-{'H} NOE was most accurately measured
for the dominant 2FDG6P resonance as 21.5 and 23%. The
other less intense '9F resonances showed similar enhance-
ments yielding NOE values of 14 and 41% for peak b, 15
and 30% for peak d, and 14 and 28% for peakf (assign-
ments as in Fig. 3).
In practice we find the implementation of '9F-{'H} to be
routine once sufficient isolation between the observe and
decouple circuits have been achieved. The new multipulse
ultra-low power decoupling schemes (20) can be employed
to further decrease tissue heating from that obtained with
gated decoupling. Although geometrically orthogonal coils
can be readily adopted to monitor fluorine chemistry in
'NMR spectral simulation was employed to map the observed net a, ,
anomer peak separation [i.e., 6,0(al) - 6(a2) vs. relative distributions of
2FDG and 2FDG6P. From this theoretically derived "calibration curve,"
a measurement of peak separation in vivo yields the concentration ratio of
2FDG6P/2FDG.
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other tissue in addition to brain, use of "electrically
orthogonal" coil designs may in some instances prove
advantageous. For example, use of a circular surface coil
for '9F observation in conjunction with a coaxial "figure
eight" coil for 'H decoupling may eliminate the restrictions
of geometrical orthogonality while maintaining sufficient
rf isolation between the two channels (21).
CONCLUSION
In summary, the substantial advantages of proton decou-
pling the fluorine nuclide in functioning cerebral tissue in
situ have been demonstrated in a standard high-field,
vertical wide-bore, high-resolution NMR spectrometer
using an orthogonal cross-coil antenna configuration.
When JFH 2lAvI/2(tissue), this methodology provides sub-
stantial improvements in the spectral resolution and signal-
to-noise of the fluorine spectrum from collapse of the scalar
coupling patterns. Additional sensitivity enhancement can
be obtained from a positive NOE. We are currently
applying '9F-{'H} NMR in the study of 2- and 3FDG
metabolism in cerebral tissue in situ.
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